MicroRNAs are highly conserved, small, single-stranded, non-coding RNA molecules that are involved in the regulation of gene expression. These molecules are transcribed by RNA polymerases II and III, that generate precursors which undergo cleavage to form mature microRNA.
MARKET DYNAMICS
The microRNA reverse transcription market is driving due to the growing prevalence of cancer neurological disorder and other medical conditions, developments in genomics technologies and increasing R&D investment in the coming years. Furthermore, growing biotechnology industry in emerging markets will create lucrative opportunities in the market.
MARKET SCOPE
The "MicroRNA Reverse Transcription Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of MicroRNA reverse transcription market with detailed market segmentation by product type, services, methods, application, and end user. The microRNA reverse transcription market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in microRNA reverse transcription market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The MicroRNA Reverse Transcription market is segmented on the basis of product type, services, methods, application, and end user. Based on product type, the market is segmented as instruments, kits and reagents, and consumables. On the basis of services, the market is categorized as sample collection, whole blood, plasma, serum, and others. Based on method, the market is segmented into quantitative PCR, in-situ hybridization, microarrays, RNA-sequencing, and others. The application segment is segmented into cancer, kidney disease, neurological disease, cardiovascular disease, and others. The end user market is segmented into academic and research institutes, biopharmaceutical companies, contract research organizations, and diagnostic centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the MicroRNA Reverse Transcription market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The MicroRNA reverse transcription market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting MicroRNA Reverse Transcription market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the MicroRNA Reverse Transcription market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the MicroRNA Reverse Transcription market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The MicroRNA reverse transcription market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting MicroRNA Reverse Transcription market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the MicroRNA Reverse Transcription market in these regions.
MARKET PLAYERS
The report covers key developments in the MicroRNA Reverse Transcription market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from MicroRNA reverse transcription market are anticipated to have lucrative growth opportunities in the future with the rising demand for MicroRNA reverse transcription in the global market. Below mentioned is the list of few companies engaged in the MicroRNA Reverse Transcription market.
The report also includes the profiles of key players in MicroRNA reverse transcription market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Agilent Technologies
- Illumina, Inc.
- Bio-Rad Laboratories Inc.
- System Biosciences LLC
- HTG Molecular Diagnostics, Inc.
- GeneCopoeia, Inc.
- New England Biolabs, Inc.
- Qiagen
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 MicroRNA Reverse Transcription Market - By Product Type
1.3.2 MicroRNA Reverse Transcription Market - By Services
1.3.3 MicroRNA Reverse Transcription Market - By Methods
1.3.4 MicroRNA Reverse Transcription Market - By Application
1.3.5 MicroRNA Reverse Transcription Market - By End User
1.3.6 MicroRNA Reverse Transcription Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MICRORNA REVERSE TRANSCRIPTION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MICRORNA REVERSE TRANSCRIPTION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MICRORNA REVERSE TRANSCRIPTION MARKET - GLOBAL MARKET ANALYSIS
6.1. MICRORNA REVERSE TRANSCRIPTION - GLOBAL MARKET OVERVIEW
6.2. MICRORNA REVERSE TRANSCRIPTION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. MICRORNA REVERSE TRANSCRIPTION MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. KITS AND REAGENTS
7.4.1. Overview
7.4.2. Kits and reagents Market Forecast and Analysis
7.5. CONSUMABLES
7.5.1. Overview
7.5.2. Consumables Market Forecast and Analysis
8. MICRORNA REVERSE TRANSCRIPTION MARKET - REVENUE AND FORECASTS TO 2028 - SERVICES
8.1. OVERVIEW
8.2. SERVICES MARKET FORECASTS AND ANALYSIS
8.3. SAMPLE COLLECTION
8.3.1. Overview
8.3.2. Sample Collection Market Forecast and Analysis
8.4. WHOLE BLOOD
8.4.1. Overview
8.4.2. Whole Blood Market Forecast and Analysis
8.5. PLASMA
8.5.1. Overview
8.5.2. Plasma Market Forecast and Analysis
8.6. SERUM
8.6.1. Overview
8.6.2. Serum Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. MICRORNA REVERSE TRANSCRIPTION MARKET - REVENUE AND FORECASTS TO 2028 - METHODS
9.1. OVERVIEW
9.2. METHODS MARKET FORECASTS AND ANALYSIS
9.3. QUANTITATIVE PCR
9.3.1. Overview
9.3.2. Quantitative PCR Market Forecast and Analysis
9.4. IN-SITU HYBRIDIZATION
9.4.1. Overview
9.4.2. In-Situ Hybridization Market Forecast and Analysis
9.5. MICROARRAYS
9.5.1. Overview
9.5.2. Microarrays Market Forecast and Analysis
9.6. RNA-SEQUENCING
9.6.1. Overview
9.6.2. RNA-Sequencing Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. MICRORNA REVERSE TRANSCRIPTION MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
10.1. OVERVIEW
10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
10.3. CANCER
10.3.1. Overview
10.3.2. Cancer Market Forecast and Analysis
10.4. KIDNEY DISEASE
10.4.1. Overview
10.4.2. Kidney Disease Market Forecast and Analysis
10.5. NEUROLOGICAL DISEASE
10.5.1. Overview
10.5.2. Neurological Disease Market Forecast and Analysis
10.6. CARDIOVASCULAR DISEASE
10.6.1. Overview
10.6.2. Cardiovascular Disease Market Forecast and Analysis
10.7. OTHERS
10.7.1. Overview
10.7.2. Others Market Forecast and Analysis
11. MICRORNA REVERSE TRANSCRIPTION MARKET - REVENUE AND FORECASTS TO 2028 - END USER
11.1. OVERVIEW
11.2. END USER MARKET FORECASTS AND ANALYSIS
11.3. ACADEMIC AND RESEARCH INSTITUTES
11.3.1. Overview
11.3.2. Academic and Research Institutes Market Forecast and Analysis
11.4. BIOPHARMACEUTICAL COMPANIES
11.4.1. Overview
11.4.2. Biopharmaceutical Companies Market Forecast and Analysis
11.5. CONTRACT RESEARCH ORGANIZATIONS
11.5.1. Overview
11.5.2. Contract Research Organizations Market Forecast and Analysis
11.6. DIAGNOSTIC CENTERS
11.6.1. Overview
11.6.2. Diagnostic Centers Market Forecast and Analysis
12. MICRORNA REVERSE TRANSCRIPTION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America MicroRNA Reverse Transcription Market Overview
12.1.2 North America MicroRNA Reverse Transcription Market Forecasts and Analysis
12.1.3 North America MicroRNA Reverse Transcription Market Forecasts and Analysis - By Product Type
12.1.4 North America MicroRNA Reverse Transcription Market Forecasts and Analysis - By Services
12.1.5 North America MicroRNA Reverse Transcription Market Forecasts and Analysis - By Methods
12.1.6 North America MicroRNA Reverse Transcription Market Forecasts and Analysis - By Application
12.1.7 North America MicroRNA Reverse Transcription Market Forecasts and Analysis - By End User
12.1.8 North America MicroRNA Reverse Transcription Market Forecasts and Analysis - By Countries
12.1.8.1 United States MicroRNA Reverse Transcription Market
12.1.8.1.1 United States MicroRNA Reverse Transcription Market by Product Type
12.1.8.1.2 United States MicroRNA Reverse Transcription Market by Services
12.1.8.1.3 United States MicroRNA Reverse Transcription Market by Methods
12.1.8.1.4 United States MicroRNA Reverse Transcription Market by Application
12.1.8.1.5 United States MicroRNA Reverse Transcription Market by End User
12.1.8.2 Canada MicroRNA Reverse Transcription Market
12.1.8.2.1 Canada MicroRNA Reverse Transcription Market by Product Type
12.1.8.2.2 Canada MicroRNA Reverse Transcription Market by Services
12.1.8.2.3 Canada MicroRNA Reverse Transcription Market by Methods
12.1.8.2.4 Canada MicroRNA Reverse Transcription Market by Application
12.1.8.2.5 Canada MicroRNA Reverse Transcription Market by End User
12.1.8.3 Mexico MicroRNA Reverse Transcription Market
12.1.8.3.1 Mexico MicroRNA Reverse Transcription Market by Product Type
12.1.8.3.2 Mexico MicroRNA Reverse Transcription Market by Services
12.1.8.3.3 Mexico MicroRNA Reverse Transcription Market by Methods
12.1.8.3.4 Mexico MicroRNA Reverse Transcription Market by Application
12.1.8.3.5 Mexico MicroRNA Reverse Transcription Market by End User
12.2. EUROPE
12.2.1 Europe MicroRNA Reverse Transcription Market Overview
12.2.2 Europe MicroRNA Reverse Transcription Market Forecasts and Analysis
12.2.3 Europe MicroRNA Reverse Transcription Market Forecasts and Analysis - By Product Type
12.2.4 Europe MicroRNA Reverse Transcription Market Forecasts and Analysis - By Services
12.2.5 Europe MicroRNA Reverse Transcription Market Forecasts and Analysis - By Methods
12.2.6 Europe MicroRNA Reverse Transcription Market Forecasts and Analysis - By Application
12.2.7 Europe MicroRNA Reverse Transcription Market Forecasts and Analysis - By End User
12.2.8 Europe MicroRNA Reverse Transcription Market Forecasts and Analysis - By Countries
12.2.8.1 Germany MicroRNA Reverse Transcription Market
12.2.8.1.1 Germany MicroRNA Reverse Transcription Market by Product Type
12.2.8.1.2 Germany MicroRNA Reverse Transcription Market by Services
12.2.8.1.3 Germany MicroRNA Reverse Transcription Market by Methods
12.2.8.1.4 Germany MicroRNA Reverse Transcription Market by Application
12.2.8.1.5 Germany MicroRNA Reverse Transcription Market by End User
12.2.8.2 France MicroRNA Reverse Transcription Market
12.2.8.2.1 France MicroRNA Reverse Transcription Market by Product Type
12.2.8.2.2 France MicroRNA Reverse Transcription Market by Services
12.2.8.2.3 France MicroRNA Reverse Transcription Market by Methods
12.2.8.2.4 France MicroRNA Reverse Transcription Market by Application
12.2.8.2.5 France MicroRNA Reverse Transcription Market by End User
12.2.8.3 Italy MicroRNA Reverse Transcription Market
12.2.8.3.1 Italy MicroRNA Reverse Transcription Market by Product Type
12.2.8.3.2 Italy MicroRNA Reverse Transcription Market by Services
12.2.8.3.3 Italy MicroRNA Reverse Transcription Market by Methods
12.2.8.3.4 Italy MicroRNA Reverse Transcription Market by Application
12.2.8.3.5 Italy MicroRNA Reverse Transcription Market by End User
12.2.8.4 Spain MicroRNA Reverse Transcription Market
12.2.8.4.1 Spain MicroRNA Reverse Transcription Market by Product Type
12.2.8.4.2 Spain MicroRNA Reverse Transcription Market by Services
12.2.8.4.3 Spain MicroRNA Reverse Transcription Market by Methods
12.2.8.4.4 Spain MicroRNA Reverse Transcription Market by Application
12.2.8.4.5 Spain MicroRNA Reverse Transcription Market by End User
12.2.8.5 United Kingdom MicroRNA Reverse Transcription Market
12.2.8.5.1 United Kingdom MicroRNA Reverse Transcription Market by Product Type
12.2.8.5.2 United Kingdom MicroRNA Reverse Transcription Market by Services
12.2.8.5.3 United Kingdom MicroRNA Reverse Transcription Market by Methods
12.2.8.5.4 United Kingdom MicroRNA Reverse Transcription Market by Application
12.2.8.5.5 United Kingdom MicroRNA Reverse Transcription Market by End User
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific MicroRNA Reverse Transcription Market Overview
12.3.2 Asia-Pacific MicroRNA Reverse Transcription Market Forecasts and Analysis
12.3.3 Asia-Pacific MicroRNA Reverse Transcription Market Forecasts and Analysis - By Product Type
12.3.4 Asia-Pacific MicroRNA Reverse Transcription Market Forecasts and Analysis - By Services
12.3.5 Asia-Pacific MicroRNA Reverse Transcription Market Forecasts and Analysis - By Methods
12.3.6 Asia-Pacific MicroRNA Reverse Transcription Market Forecasts and Analysis - By Application
12.3.7 Asia-Pacific MicroRNA Reverse Transcription Market Forecasts and Analysis - By End User
12.3.8 Asia-Pacific MicroRNA Reverse Transcription Market Forecasts and Analysis - By Countries
12.3.8.1 Australia MicroRNA Reverse Transcription Market
12.3.8.1.1 Australia MicroRNA Reverse Transcription Market by Product Type
12.3.8.1.2 Australia MicroRNA Reverse Transcription Market by Services
12.3.8.1.3 Australia MicroRNA Reverse Transcription Market by Methods
12.3.8.1.4 Australia MicroRNA Reverse Transcription Market by Application
12.3.8.1.5 Australia MicroRNA Reverse Transcription Market by End User
12.3.8.2 China MicroRNA Reverse Transcription Market
12.3.8.2.1 China MicroRNA Reverse Transcription Market by Product Type
12.3.8.2.2 China MicroRNA Reverse Transcription Market by Services
12.3.8.2.3 China MicroRNA Reverse Transcription Market by Methods
12.3.8.2.4 China MicroRNA Reverse Transcription Market by Application
12.3.8.2.5 China MicroRNA Reverse Transcription Market by End User
12.3.8.3 India MicroRNA Reverse Transcription Market
12.3.8.3.1 India MicroRNA Reverse Transcription Market by Product Type
12.3.8.3.2 India MicroRNA Reverse Transcription Market by Services
12.3.8.3.3 India MicroRNA Reverse Transcription Market by Methods
12.3.8.3.4 India MicroRNA Reverse Transcription Market by Application
12.3.8.3.5 India MicroRNA Reverse Transcription Market by End User
12.3.8.4 Japan MicroRNA Reverse Transcription Market
12.3.8.4.1 Japan MicroRNA Reverse Transcription Market by Product Type
12.3.8.4.2 Japan MicroRNA Reverse Transcription Market by Services
12.3.8.4.3 Japan MicroRNA Reverse Transcription Market by Methods
12.3.8.4.4 Japan MicroRNA Reverse Transcription Market by Application
12.3.8.4.5 Japan MicroRNA Reverse Transcription Market by End User
12.3.8.5 South Korea MicroRNA Reverse Transcription Market
12.3.8.5.1 South Korea MicroRNA Reverse Transcription Market by Product Type
12.3.8.5.2 South Korea MicroRNA Reverse Transcription Market by Services
12.3.8.5.3 South Korea MicroRNA Reverse Transcription Market by Methods
12.3.8.5.4 South Korea MicroRNA Reverse Transcription Market by Application
12.3.8.5.5 South Korea MicroRNA Reverse Transcription Market by End User
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa MicroRNA Reverse Transcription Market Overview
12.4.2 Middle East and Africa MicroRNA Reverse Transcription Market Forecasts and Analysis
12.4.3 Middle East and Africa MicroRNA Reverse Transcription Market Forecasts and Analysis - By Product Type
12.4.4 Middle East and Africa MicroRNA Reverse Transcription Market Forecasts and Analysis - By Services
12.4.5 Middle East and Africa MicroRNA Reverse Transcription Market Forecasts and Analysis - By Methods
12.4.6 Middle East and Africa MicroRNA Reverse Transcription Market Forecasts and Analysis - By Application
12.4.7 Middle East and Africa MicroRNA Reverse Transcription Market Forecasts and Analysis - By End User
12.4.8 Middle East and Africa MicroRNA Reverse Transcription Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa MicroRNA Reverse Transcription Market
12.4.8.1.1 South Africa MicroRNA Reverse Transcription Market by Product Type
12.4.8.1.2 South Africa MicroRNA Reverse Transcription Market by Services
12.4.8.1.3 South Africa MicroRNA Reverse Transcription Market by Methods
12.4.8.1.4 South Africa MicroRNA Reverse Transcription Market by Application
12.4.8.1.5 South Africa MicroRNA Reverse Transcription Market by End User
12.4.8.2 Saudi Arabia MicroRNA Reverse Transcription Market
12.4.8.2.1 Saudi Arabia MicroRNA Reverse Transcription Market by Product Type
12.4.8.2.2 Saudi Arabia MicroRNA Reverse Transcription Market by Services
12.4.8.2.3 Saudi Arabia MicroRNA Reverse Transcription Market by Methods
12.4.8.2.4 Saudi Arabia MicroRNA Reverse Transcription Market by Application
12.4.8.2.5 Saudi Arabia MicroRNA Reverse Transcription Market by End User
12.4.8.3 U.A.E MicroRNA Reverse Transcription Market
12.4.8.3.1 U.A.E MicroRNA Reverse Transcription Market by Product Type
12.4.8.3.2 U.A.E MicroRNA Reverse Transcription Market by Services
12.4.8.3.3 U.A.E MicroRNA Reverse Transcription Market by Methods
12.4.8.3.4 U.A.E MicroRNA Reverse Transcription Market by Application
12.4.8.3.5 U.A.E MicroRNA Reverse Transcription Market by End User
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America MicroRNA Reverse Transcription Market Overview
12.5.2 South and Central America MicroRNA Reverse Transcription Market Forecasts and Analysis
12.5.3 South and Central America MicroRNA Reverse Transcription Market Forecasts and Analysis - By Product Type
12.5.4 South and Central America MicroRNA Reverse Transcription Market Forecasts and Analysis - By Services
12.5.5 South and Central America MicroRNA Reverse Transcription Market Forecasts and Analysis - By Methods
12.5.6 South and Central America MicroRNA Reverse Transcription Market Forecasts and Analysis - By Application
12.5.7 South and Central America MicroRNA Reverse Transcription Market Forecasts and Analysis - By End User
12.5.8 South and Central America MicroRNA Reverse Transcription Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil MicroRNA Reverse Transcription Market
12.5.8.1.1 Brazil MicroRNA Reverse Transcription Market by Product Type
12.5.8.1.2 Brazil MicroRNA Reverse Transcription Market by Services
12.5.8.1.3 Brazil MicroRNA Reverse Transcription Market by Methods
12.5.8.1.4 Brazil MicroRNA Reverse Transcription Market by Application
12.5.8.1.5 Brazil MicroRNA Reverse Transcription Market by End User
12.5.8.2 Argentina MicroRNA Reverse Transcription Market
12.5.8.2.1 Argentina MicroRNA Reverse Transcription Market by Product Type
12.5.8.2.2 Argentina MicroRNA Reverse Transcription Market by Services
12.5.8.2.3 Argentina MicroRNA Reverse Transcription Market by Methods
12.5.8.2.4 Argentina MicroRNA Reverse Transcription Market by Application
12.5.8.2.5 Argentina MicroRNA Reverse Transcription Market by End User
13. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET
13.1 North America
13.2 Europe
13.3 Asia-Pacific
13.4 Rest of the World
14. INDUSTRY LANDSCAPE
14.1. MERGERS AND ACQUISITIONS
14.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
14.3. NEW PRODUCT LAUNCHES
14.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
15. MICRORNA REVERSE TRANSCRIPTION MARKET, KEY COMPANY PROFILES
15.1. MERCK KGAA
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Products and Services
15.1.4. Financial Overview
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. THERMO FISHER SCIENTIFIC, INC.
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Products and Services
15.2.4. Financial Overview
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. AGILENT TECHNOLOGIES
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Products and Services
15.3.4. Financial Overview
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. ILLUMINA, INC.
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Products and Services
15.4.4. Financial Overview
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. BIO-RAD LABORATORIES INC.
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Products and Services
15.5.4. Financial Overview
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. SYSTEM BIOSCIENCES LLC
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Products and Services
15.6.4. Financial Overview
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. HTG MOLECULAR DIAGNOSTICS, INC.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Products and Services
15.7.4. Financial Overview
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. GENECOPOEIA, INC
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Products and Services
15.8.4. Financial Overview
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. NEW ENGLAND BIOLABS, INC.
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Products and Services
15.9.4. Financial Overview
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. QIAGEN
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Products and Services
15.10.4. Financial Overview
15.10.5. SWOT Analysis
15.10.6. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
1. Merck KGaA
2. Thermo Fisher Scientific, Inc.
3. Agilent Technologies
4. Illumina, Inc.
5. Bio-Rad Laboratories Inc.
6. System Biosciences LLC
7. HTG Molecular Diagnostics, Inc.
8. GeneCopoeia, Inc.
9. New England Biolabs, Inc.
10. Qiagen
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For